Dechra Pharmaceuticals PLC
LSE:DPH
Dechra Pharmaceuticals PLC
LSE:DPH
Price:
3 866 GBX
Updated:
May 10, 2024
Dechra Pharmaceuticals PLC
Cash from Operating Activities
|
Dechra Pharmaceuticals PLC
Cash from Operating Activities Peer Comparison
Comparables:
GSK
AZN
VRNA
INDV
HIK
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Operating Activities
£63.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Operating Activities
£7.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Operating Activities
$9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
33%
|
CAGR 10-Years
4%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Cash from Operating Activities
-$50.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Cash from Operating Activities
-$334m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Operating Activities
$608m
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
See Also
What is Dechra Pharmaceuticals PLC's Cash from Operating Activities?
Cash from Operating Activities
63.6m
GBP
63.6m
GBP
Based on the financial report for Jun 30, 2023, Dechra Pharmaceuticals PLC's Cash from Operating Activities amounts to 63.6m GBP.
What is Dechra Pharmaceuticals PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
6%
6%
Over the last year, the Cash from Operating Activities growth was -48%. The average annual Cash from Operating Activities growth rates for Dechra Pharmaceuticals PLC have been -16% over the past three years , and 6% over the past ten years .
You don't have any saved screeners yet
